Skip to main content
. 2021 Jul 14;40(23):5096–5114. doi: 10.1002/sim.9113

FIGURE 4.

SIM-9113-FIG-0004-b

Inclusion process of the simulated trial under a modified continual reassessment method (CRM). The type of dose limiting toxicity (DLT) is specified by the type of point, and the administration of occurrence of each type of DLT is given. The global number of DLT observed in each cohort of three patients is provided under each horizontal bar